Search research articles
Contact Us
Filters
Showing results (171-180 of 190) with videos related to
Page
of 19
Sort By:
The American Journal of Gastroenterology
|
July 4, 2020
Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase
Carla F Murillo Perez, Maren H Harms, Keith D Lindor, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 11, 2020
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis
Alessio Gerussi, Davide Paolo Bernasconi, Sarah Elisabeth O'Donnell, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 9, 2023
Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival
C Fiorella Murillo Perez, Stephanie Ioannou, Iman Hassanally, et al.
Journal of Hepatology
|
December 13, 2021
Corrigendum to 'An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs' [J Hepatol 2021;75(3):572-581]
Heather J Cordell, James J Fryett, Kazuko Ueno, et al.
The Lancet. Gastroenterology & Hepatology
|
July 19, 2018
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score
Marco Carbone, Alessandra Nardi, Steve Flack, et al.
Journal of Hepatology
|
January 13, 2023
Corrigendum to: "An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs" [J Hepatol 75 (2021) 572-581]
Heather J Cordell, James J Fryett, Kazuko Ueno, et al.
Journal of Hepatology
|
May 25, 2021
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs
Heather J Cordell, James J Fryett, Kazuko Ueno, et al.
Gastroenterology
|
September 23, 2022
Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls
C Fiorella Murillo Perez, Holly Fisher, Shaun Hiu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 14, 2024
Noninvasive Assessment of portal Hypertension in Patients With Primary Biliary Cholangitis is Affected by Severity of Cholestasis
Vincenza Calvaruso, Ciro Celsa, Laura Cristoferi, et al.
Journal of Hepatology
|
July 1, 2022
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis
Christophe Corpechot, Fabrice Carrat, Farid Gaouar, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 190) with videos related to
Sort By:
Page
of 19
The American Journal of Gastroenterology
|
July 4, 2020
Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase
Carla F Murillo Perez, Maren H Harms, Keith D Lindor, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 11, 2020
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis
Alessio Gerussi, Davide Paolo Bernasconi, Sarah Elisabeth O'Donnell, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 9, 2023
Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival
C Fiorella Murillo Perez, Stephanie Ioannou, Iman Hassanally, et al.
Journal of Hepatology
|
December 13, 2021
Corrigendum to 'An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs' [J Hepatol 2021;75(3):572-581]
Heather J Cordell, James J Fryett, Kazuko Ueno, et al.
The Lancet. Gastroenterology & Hepatology
|
July 19, 2018
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score
Marco Carbone, Alessandra Nardi, Steve Flack, et al.
Journal of Hepatology
|
January 13, 2023
Corrigendum to: "An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs" [J Hepatol 75 (2021) 572-581]
Heather J Cordell, James J Fryett, Kazuko Ueno, et al.
Journal of Hepatology
|
May 25, 2021
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs
Heather J Cordell, James J Fryett, Kazuko Ueno, et al.
Gastroenterology
|
September 23, 2022
Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls
C Fiorella Murillo Perez, Holly Fisher, Shaun Hiu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 14, 2024
Noninvasive Assessment of portal Hypertension in Patients With Primary Biliary Cholangitis is Affected by Severity of Cholestasis
Vincenza Calvaruso, Ciro Celsa, Laura Cristoferi, et al.
Journal of Hepatology
|
July 1, 2022
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis
Christophe Corpechot, Fabrice Carrat, Farid Gaouar, et al.
Page
of 19